Michał Pochopień

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Michał Pochopień is an author at Creativ-Ceutical (France) specializing in cost-effectiveness analysis, pharmacoeconomic modeling, and cost-effectiveness.

Publications per year

2019–2023

Publications

Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes

Michał Pochopień · The American Journal of Managed Care · 2022 · 25 citations

Pharmacy, Nephrology, Pharmacoeconomics +14

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Michał Pochopień, Annette B. Beiderbeck, Phil McEwan et al. · BMC Health Services Research · 2019 · 19 citations · Full text

Pharmacy, Ophthalmology, Pharmacoeconomics +17

Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands

S. W. Quist, Alexander V. van Schoonhoven, Stephan J. L. Bakker et al. · Cardiovascular Diabetology · 2023 · 19 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting

Zalmaï Hakimi, Koo Wilson, Eoin McAughey et al. · Journal of Comparative Effectiveness Research · 2022 · 12 citations

Pharmacy, Hematology, Pharmacotherapy +15

1–4 of 4